(Q37057994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

metastatic breast cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Paolo Pronzato

series ordinal

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

139-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18197722%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

12 December 2020

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

1 reference

12 December 2020

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

1 reference

12 December 2020

Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA

1 reference

12 December 2020

Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.

1 reference

12 December 2020

Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone.

1 reference

12 December 2020

Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine

1 reference

12 December 2020

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

1 reference

12 December 2020

High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells

1 reference

12 December 2020

Is breast cancer survival improving?

1 reference

12 December 2020

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

1 reference

12 December 2020

Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis

1 reference

12 December 2020

Targeting the microtubules in breast cancer beyond taxanes: the epothilones

1 reference

12 December 2020

The role of DNA mismatch repair in drug resistance.

1 reference

12 December 2020

Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

1 reference

12 December 2020

Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties

1 reference

12 December 2020

Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.

1 reference

12 December 2020

Anthracycline resistance: the problem and its current definition

1 reference

12 December 2020

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy

1 reference

12 December 2020

Ixabepilone and the narrow path to developing new cytotoxic drugs

1 reference

12 December 2020

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

12 December 2020

A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days.

1 reference

12 December 2020

The biology and medicinal chemistry of epothilones

1 reference

12 December 2020

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

1 reference

12 December 2020

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

12 December 2020

A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review).

1 reference

12 December 2020

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

1 reference

12 December 2020

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.

1 reference

12 December 2020

Advanced breast cancer: chemotherapy phase III trials that change a standard

1 reference

12 December 2020

Resistance to antimitotic agents as genetic probes of microtubule structure and function

1 reference

12 December 2020

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy

1 reference

12 December 2020

Epothilones: mechanism of action and biologic activity

1 reference

12 December 2020

Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days.

1 reference

12 December 2020

Chemoresistance in breast tumors

1 reference

12 December 2020